Arizona Rh Incompatibility Birth Injury Lawyer

Compassionate Legal Advocacy for Preventable Birth Injuries in Arizona

Understanding Rh Incompatibility and Hemolytic Disease of the Newborn

Rh incompatibility occurs when an Rh-negative mother carries an Rh-positive fetus, causing her immune system to produce antibodies that attack the baby’s red blood cells. The Rh factor, a protein known as the D antigen found on the surface of red blood cells, is either present (Rh-positive) or absent (Rh-negative). When a mother lacks this protein and her baby has it, a dangerous immune response can develop.

The process begins with sensitization. During pregnancy or delivery, small amounts of fetal blood can cross the placental barrier and enter the mother’s bloodstream. Her immune system recognizes the Rh-positive cells as foreign and produces antibodies against them. In a first pregnancy, this sensitization event often occurs late enough that the baby is not significantly affected.

But in subsequent pregnancies with an Rh-positive fetus, those antibodies are already present. They cross the placenta, target the baby’s red blood cells, and begin destroying them. This immune attack does not stop on its own; as long as the antibodies are present, they continue to hemolyze, or destroy, fetal cells, worsening the anemia. Research published in PLOS Computational Biology on placental IgG transfer confirms how efficiently maternal antibodies pass through the placenta, especially later in pregnancy.

This destruction of red blood cells leads to hemolytic disease of the newborn (HDN), a condition where the baby becomes severely anemic and develops dangerous levels of bilirubin as the body breaks down the damaged cells. HDN can range from mild jaundice to life-threatening organ failure.

Rh incompatibility is not the only type of blood group conflict. ABO incompatibility also involves a mismatch between maternal and fetal blood types, though it behaves differently. A comparative analysis published in PubMed Central examined treatment outcomes for both conditions, and Rh incompatibility injury attorneys often need to distinguish between the two when building a case.

Feature	Rh Incompatibility	ABO Incompatibility
Cause	Rh-negative mother, Rh-positive baby	Mother is type O; baby is type A, B, or AB
Sensitization required?	Yes, usually from a prior pregnancy or event	No; can occur in the first pregnancy
Typical severity	Can be severe or fatal without treatment	Usually mild to moderate
Risk in subsequent pregnancies	Increases significantly with each pregnancy	Does not typically worsen over time

The Medical Standard of Care for Preventing Rh Sensitization

The standard of care mandates that obstetricians screen all pregnant women for blood type and antibodies early in pregnancy and administer Rh immune globulin (RhoGAM) at specific intervals to prevent sensitization. Rh immune globulin (RhoGAM), a blood product that prevents the mother’s immune system from producing anti-Rh antibodies, blocks the recognition of positive cells. When given at the right time, it is remarkably effective.

Screening begins at the first prenatal visit with a comprehensive antibody screening and Indirect Coombs test, a blood test that detects whether the mother has already developed Rh antibodies from a previous pregnancy or sensitizing event. According to the NCBI Bookshelf resource on Rho(D) Immune Globulin, the established protocol calls for RhoGAM administration at 28 weeks of gestation and again within 72 hours after delivery if the baby is confirmed Rh-positive. Missing either of these windows can leave the mother unprotected and allow sensitization to occur.

Our legal team includes former defense attorneys and hospital nurses who previously worked for the systems they now challenge, providing strategic insight into hospital protocols. Failures are not always limited to the 28-week and postpartum doses. The following events also require RhoGAM, and doctors may sometimes overlook them:

• Miscarriage or ectopic pregnancy
• Elective or therapeutic abortion
• Amniocentesis or chorionic villus sampling
• Abdominal trauma during pregnancy
• External cephalic version (manually turning a breech baby)
• Significant vaginal bleeding during pregnancy

Unique Risks of Non-Obvious Sensitization Triggers

Sensitization, the process by which the mother’s immune system begins producing antibodies against Rh-positive blood, does not only happen during delivery. Any event that causes fetal-maternal hemorrhage, meaning fetal blood cells leak into the mother’s circulation, can trigger it. A car accident during pregnancy, a fall, or even a routine procedure like amniocentesis can cause enough mixing of blood to start the immune response.

Many parents are unaware that these events carry Rh-related risk. If a provider fails to recognize the need for RhoGAM after one of these triggers, the sensitization may go undetected until the next pregnancy, when the consequences are far more severe.

Diagnosing and Treating Fetal Anemia and Newborn Complications

Doctors diagnose fetal anemia using Doppler ultrasound to measure blood flow speed and treat severe cases with intrauterine blood transfusions or early delivery followed by phototherapy. The fetal anemia identified by these tests requires careful management to prevent long-term neurological damage. The key diagnostic tool is middle cerebral artery Doppler peak systolic velocity (MCA-PSV), a non-invasive ultrasound measurement that tracks how fast blood flows through the baby’s brain. When a fetus is anemic, its blood becomes thinner and moves faster, producing measurably elevated velocities. A study published in the International Medical Review Press on fetal hydrops and MCA Doppler confirms that MCA-PSV is a reliable, non-invasive predictor of fetal anemia that helps guide the timing of treatment.

When fetal anemia is identified, treatment follows a clear escalation:

• Mild cases: Monitoring with serial Doppler ultrasounds and antibody titer checks.
• Moderate anemia: Intrauterine transfusion (IUT), a procedure where compatible blood is transfused directly into the fetus through the umbilical cord, to correct anemia before delivery.
• Severe or late-stage anemia: Early delivery followed by phototherapy (light therapy that breaks down excess bilirubin in the newborn’s skin) or exchange transfusion for critical hyperbilirubinemia, where dangerously high bilirubin levels require the newborn’s blood to be partially replaced.

The most dangerous outcome of untreated severe fetal anemia is hydrops fetalis, a condition in which massive fluid accumulates in the baby’s tissues and body cavities. Hydrops fetalis carries an extremely high mortality rate. The fluid buildup places immense strain on the fetus’s heart and lungs, often leading to heart failure in utero if not treated aggressively. A Phoenix Rh disease attorney reviewing these cases will look closely at whether providers ordered timely MCA-PSV monitoring and acted on the results.

Proving Medical Malpractice in Rh Incompatibility Cases

Proving malpractice requires demonstrating that the provider failed to screen for antibodies, neglected to administer RhoGAM, or failed to monitor and treat a sensitized pregnancy, directly causing the infant’s injury. Establishing medical negligence requires a detailed comparison of the actions taken by your providers against the accepted protocols of the obstetrical community. Our legal team uses insider knowledge from former defense attorneys to anticipate how medical facilities might explain these errors.

Failure to screen. If a provider did not check the mother’s blood type and antibody status at the first prenatal visit, any resulting sensitization and fetal harm may trace directly to that omission.

Failure to administer RhoGAM. Missing the 28-week dose, the postpartum dose, or a dose after a sensitizing event like miscarriage or trauma leaves the mother vulnerable. The records should document each administration. Gaps in that documentation can be powerful evidence.

Failure to monitor a sensitized pregnancy. Once antibodies are detected, the standard of care requires regular titer checks and Doppler monitoring. Hyperbilirubinemia, dangerously elevated bilirubin levels in the newborn, can cause kernicterus, a form of permanent brain damage caused by bilirubin deposits in the brain. If rising antibody levels or signs of jaundice were ignored or treated too late, that delay may constitute negligence. Your legal team will scrutinize the fetal monitoring strips and lab reports to pinpoint exactly when the distress became evident.

Multi-party liability. Not every error begins with the obstetrician. According to transfusion-related error data reported to the CDC’s National Healthcare Safety Network Hemovigilance Module, blood typing and crossmatching mistakes do occur. If a laboratory or blood bank misidentified the mother’s Rh type or misreported an Indirect Coombs test result, those entities may share liability. When suing for Rh incompatibility negligence, our team investigates every provider in the chain, including hospital systems, independent labs, and blood banks, to identify where the breakdown occurred.

Our in-house medical staff, including nurse practitioners and board-certified patient advocates, review clinical records alongside our attorneys to reconstruct the timeline of care and identify each point where the standard was not met.

Compensation for Long-Term Injuries and Wrongful Death

Families may recover compensation for past and future medical expenses, life-care planning for permanent disabilities like cerebral palsy, lost earning capacity, and pain and suffering. The financial scope of these cases often extends across a child’s entire lifetime.

A child who develops kernicterus or other brain damage from untreated Rh disease may require ongoing therapies, specialized education, adaptive equipment, and round-the-clock care. Specialized life-care planning, developed by medical and vocational experts, projects these costs over decades. These plans are essential to ensure a settlement or verdict actually covers the child’s real needs rather than a discounted estimate.

In the most tragic cases, severe hydrops fetalis can lead to stillbirth or neonatal death. Families in this situation may pursue a wrongful death claim to recover damages for their loss, including funeral expenses, loss of companionship, and the emotional suffering that follows.

We prepare every case as if it will go to trial from the very beginning. By working with qualified medical experts and building a complete damages picture early, we maintain a firm negotiation posture. Our goal is simple: to ensure any resolution reflects the full, lifetime impact on your child and your family.

Contact the Arizona Birth Injury Attorneys at Hastings Law Firm Today for Help

Rh disease is one of the most preventable complications in modern obstetrics. Our team is led by board-certified trial lawyer Tommy Hastings, who has spent over two decades enforcing accountability and improving patient safety standards. The screenings are routine, and the treatment is effective. When a baby is harmed because a provider skipped a step or missed a critical window, that family deserves answers.

At Hastings Law Firm, our team of attorneys, former defense counsel, and in-house medical professionals investigates these cases with the depth and precision they demand. We understand that your trust in the healthcare system has been shaken, and we are here to help you find the truth about what happened.

If your child was injured by what you believe was a failure to prevent or manage Rh incompatibility, contact our Arizona medical malpractice firm for a free, confidential case evaluation. You pay no fees or costs unless we recover compensation on your behalf. Call us today or complete our online form to take the first step.